247 related articles for article (PubMed ID: 19068380)
41. Autologous serum for anterior tissue necrosis after porous orbital implant.
Kamal S; Kumar S; Goel R
Middle East Afr J Ophthalmol; 2014; 21(2):193-5. PubMed ID: 24791115
[TBL] [Abstract][Full Text] [Related]
42. Posterior auricular muscle patch graft for exposed orbital implant.
Liu CY; Sun MG; Jones S; Setabutr P
Orbit; 2019 Apr; 38(2):144-147. PubMed ID: 29652206
[TBL] [Abstract][Full Text] [Related]
43. Tarsal patch-flap for orbital implant exposure.
Soparkar CN; Patrinely JR
Ophthalmic Plast Reconstr Surg; 1998 Nov; 14(6):391-7. PubMed ID: 9842558
[TBL] [Abstract][Full Text] [Related]
44. Hydroxyapatite motility implants in ocular prosthetics.
Cowper TR
J Prosthet Dent; 1995 Mar; 73(3):267-73. PubMed ID: 7760276
[TBL] [Abstract][Full Text] [Related]
45. Re: "The porous polyethylene (Medpor) spherical orbital implant: a retrospective study of 136 cases".
Mittal R; Thomas R; Naik M; Honavar SG
Ophthalmic Plast Reconstr Surg; 2004 Sep; 20(5):403; author reply 403-4. PubMed ID: 15377917
[No Abstract] [Full Text] [Related]
46. Epithelial downgrowth complicating evisceration with orbital implant exposure.
Ghaiy R; Meyer DR; Farber MA
Arch Ophthalmol; 2005 Sep; 123(9):1268-70. PubMed ID: 16157812
[No Abstract] [Full Text] [Related]
47. Comparison between motility of biointegratable and silicone orbital implants.
Yazici B
Am J Ophthalmol; 2007 Nov; 144(5):786-7; author reply 787. PubMed ID: 17964325
[No Abstract] [Full Text] [Related]
48. Re: "long-term follow-up of porous polyethylene spherical implants after enucleation and evisceration".
Jordan DR
Ophthalmic Plast Reconstr Surg; 2007; 23(6):500-1; author reply 501. PubMed ID: 18030136
[No Abstract] [Full Text] [Related]
49. Enduragen patch grafts for exposed orbital implants.
Wu AY; Vagefi MR; Georgescu D; Burroughs JR; Anderson RL
Orbit; 2011 Mar; 30(2):92-5. PubMed ID: 21438730
[TBL] [Abstract][Full Text] [Related]
50. Enucleation versus evisceration.
O'Donnell BA; Kersten R; McNab A; Rose G; Rosser P
Clin Exp Ophthalmol; 2005 Feb; 33(1):5-9. PubMed ID: 15670071
[TBL] [Abstract][Full Text] [Related]
51. Re: "long-term follow-up of porous polyethylene spherical implants after enucleation and evisceration".
Fountain TR
Ophthalmic Plast Reconstr Surg; 2007; 23(6):500; author reply 501. PubMed ID: 18030137
[No Abstract] [Full Text] [Related]
52. Polyglactin mesh wrapping of hydroxyapatite implants.
Jordan DR
Ophthalmic Plast Reconstr Surg; 2001 May; 17(3):221-3. PubMed ID: 11388390
[No Abstract] [Full Text] [Related]
53. Orbital augmentation with injectable calcium hydroxylapatite for correction of postenucleation/evisceration socket syndrome.
Vagefi MR; McMullan TF; Burroughs JR; Georgescu D; McCann JD; Anderson RL
Ophthalmic Plast Reconstr Surg; 2011; 27(2):90-4. PubMed ID: 20683373
[TBL] [Abstract][Full Text] [Related]
54. Orbital implants: potential new directions.
Hicks CR; Morrison D; Lou X; Crawford GJ; Gadjatsy A; Constable IJ
Expert Rev Med Devices; 2006 Nov; 3(6):805-15. PubMed ID: 17280545
[TBL] [Abstract][Full Text] [Related]
55. [Late changes in a recipient's tissues after implantation of synthetic hydroxyapatite of varying density: an experimental morphological study].
Dushin NV; Ivanov VIu; Fedorov AA; Shkliaruk VV; Severin VA
Vestn Oftalmol; 2005; 121(6):38-40. PubMed ID: 16405064
[TBL] [Abstract][Full Text] [Related]
56. Re: "a case of bilateral silent sinus syndrome presenting with chronic ocular surface disease".
Ferri A; Ferri T; Sesenna E
Ophthalmic Plast Reconstr Surg; 2011; 27(5):393; author reply 393-4. PubMed ID: 21904177
[No Abstract] [Full Text] [Related]
57. Elevated white blood cell count may predict risk of orbital implant exposure.
Bee YS; Lin MC; Sheu SJ; Ng JD
Can J Ophthalmol; 2014 Feb; 49(1):45-9. PubMed ID: 24513356
[TBL] [Abstract][Full Text] [Related]
58. Evisceration: a new technique of trans-scleral implant placement.
Long JA; Tann TM; Girkin CA
Ophthalmic Plast Reconstr Surg; 2000 Sep; 16(5):322-5. PubMed ID: 11021379
[TBL] [Abstract][Full Text] [Related]
59. [Anophthalmic cavity and implant extrusion].
Schellini SA; Ichida FK; Padovani CR
Arq Bras Oftalmol; 2007; 70(5):752-5. PubMed ID: 18157296
[TBL] [Abstract][Full Text] [Related]
60. Management of porous orbital implants requiring explantation: a clinical and histopathological study.
Quaranta-Leoni FM; Moretti C; Sposato S; Nardoni S; Lambiase A; Bonini S
Ophthalmic Plast Reconstr Surg; 2014; 30(2):132-6. PubMed ID: 24614545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
